<DOC>
	<DOCNO>NCT01007617</DOCNO>
	<brief_summary>Oral mucositis represent major complication cytotoxic chemotherapy among cancer child . Low-power laser therapy ( LPLT ) use reduce incidence oral mucositis patient receive high-dose chemotherapy . The aim study compare two preventive energy deliver LPLT oral mucosa decrease severity mucositis child .</brief_summary>
	<brief_title>Low-energy Laser Therapy Prevention Oral Mucositis Children</brief_title>
	<detailed_description>Mucositis one main complication cytotoxic chemotherapy total body irradiation child cancer . Local systemic treatment efficiency limit side effect , ( particularly opioid ) . Two randomized recent study adult show efficiency LPLT ( wavelength 650nm intensity 4J/cm² ) prevention severe mucositis . In pediatrics patient , one randomize study perform intensity 4J/cm² wavelength 732nm , show evidence profit . In theory , tissue absorption level laser similar 650 900nm low around 700nm . Procedure well tolerated child ; main limiting factor deadline directly proportional intensity deliver . The aim study compare two preventive energy ( 2J/cm² 8 J/cm² ) daily deliver LPLT oral mucosa decrease severity mucositis child . Placebo study possible opinion prefer compare two intensity LPLT three reason : give sensation heat generate treatment , true placebo difficult obtain ; consider difficulty proceed large-sized clinical trial population , seem u necessary end quickly optimal protocol ; main inconvenience LPLT duration session , case negative result , study generate data allow realize useless long session . It 's prospective control study , randomize double blind phase II , one center . All patient receive LPLT ( GaAlAs , wavelength 980nm ) daily 1st 5th day cytotoxic treatment . The patient randomize 2 group accord deliver dose : 2 J/cm2/d 8 J/cm2/d . Main evaluation criterion : mucositis maximal intensity ( WHO scale ) Secondary evaluation criterion : mucositis duration , mucositis survival free , pain , opioid treatment , hospitalization , fever infection , nutrition . Expected clinical effect : improvement child 's comfort ; dissemination technique oncology pediatric center</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<criteria>0 18 year patient receive therapy agent likely cause severe mucositis ( grade 3 4 ) Patients develop severe mucositis previously chemotherapy , receive . Healthy oral mucosa inform consent Infection active prove , viral , bacterial fungal oral cavity Malignant pathology oral cavity Preliminary local irradiation oral cavity Simultaneous treatment agent prevention treatment mucositis investigation Inclusion protocol oral mucositis one assessment criterion Absence consent lit parent child</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Children</keyword>
	<keyword>Cancer</keyword>
	<keyword>Mucositis</keyword>
	<keyword>Laser</keyword>
	<keyword>Prevention</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Children malignancy receive chemotherapy and/or radiotherapy induce severe mucositis</keyword>
</DOC>